New Business Models
Meet consumer demands and remain competitive
Scientific and technological breakthroughs require systems that can keep up with the pace of change. Yet the current reimbursement model doesn’t necessarily support the most innovative and promising solutions. Innovators are left with the challenge of how to ensure their strategy demonstrates the right value so they can get paid – or find a way to be paid outside of the traditional system. Ultimately, policymakers, payers, providers and suppliers need to urgently rethink how they work if we are to help innovation thrive. We continue to voice the need to reshape incentives with new business models in order to support the development and growth of new digital health technologies.
On Tuesday 1 December, the session will look at the business landscape and discuss new business models across the EU and US with case study examples, followed by a look at digitalisation and innovation from an EU perspective.
We bring together moderator Kurt Höller, Director of Business Creation at EIT Health and Ariel Stern, Associate Professor, Harvard Business School to discuss the business landscape in Europe. Then with Gottfried Ludewig, Director General, Digitalisation and Innovation, German Federal Ministry of Health and Kristina Lagerstedt, CEO, 1928 Diagnostics, the four-panel speakers will come together to discuss and debate around the topic of innovation and hindrance.
